GC-MS analysis of ethanolic extract of Momordica charantia fruit
Journal of Drug Delivery and Therapeutics · 15.07.2026 · 16 (7) · 33-43
DOI: 10.22270/jddt.v16i7.7858 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Drug Delivery and Therapeutics, online erschienen am 15.07.2026. Verfasst von Brij Raj Singh und 2 weiteren Autor:innen. Die Arbeit nennt 20 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).
Abstract (Originalsprache)
Researchers are particularly interested in medicinal plants because most pharmaceutical businesses use them to make pharmaceutical compounds. Traditionally, especially in India, a large number of compounds utilized as food colors, tastes, perfumes, and medicinal biochemicals are obtained from plants. Most herbal treatments and their derivative products were often made from crude plant extracts, which are a complex mixture of various phytochemical constituents (plant secondary metabolites). The chemical properties of these components differ greatly between species. The GC-MS method employed for the study of the extracted materials is an interesting instrument for figuring out the concentration of specific active principles in herbs used in the food, pharmaceutical, cosmetic, or pharmaceutical industries. The aim of this work was to discover bioactive compounds from the ethanolic fruit extract of Momordica charantia using gas chromatography and mass spectrometry (GC-MS). The GCMS-QP2010 Ultra Version was used to perform GCMS analysis of the ethanolic extract in accordance with standard procedure. The findings demonstrated the presence of various 32 phytochemicals, including heptacosanoic acid, Eicosanoic acid,Eicosanoic acid, Undecanoic acid, docanoic acid, decanal, 1-(Pyrrolidin-3-yl) pyrazole, Tricotanoic acid in the ethanolic extract of M. charantia. Because of the ethanolic extract contains secondary metabolites, the M. charantia may have anti-inflammatory, Antifungal, neurological disorders, anti-tumor, anti-microbial, antioxidant, and antidiabetic properties. These results support the traditional use of M. charantia for a number of ailments. Further research is needed to determine the extract's active ingredient and elucidate its exact method of action in a range of ailments. Keywords: 1-(Pyrrolidin-3-yl) pyrazole, M. charantia, Heptacosanoic acid, Eicosanoic acid, Decanal
Zitieren
APA
Singh, B. R., Verma, A., & Yadav, V. K. (2026). GC-MS analysis of ethanolic extract of Momordica charantia fruit. Journal of Drug Delivery and Therapeutics, 16(7), 33-43. https://doi.org/10.22270/jddt.v16i7.7858
Vancouver
Singh BR, Verma A, Yadav VK. GC-MS analysis of ethanolic extract of Momordica charantia fruit. Journal of Drug Delivery and Therapeutics. 2026;16(7):33-43. doi:10.22270/jddt.v16i7.7858
BibTeX
@article{Singh2026,
author = {Singh, Brij Raj and Verma, Amita and Yadav, Vinay Kumar},
title = {GC-MS analysis of ethanolic extract of Momordica charantia fruit},
journal = {Journal of Drug Delivery and Therapeutics},
year = {2026},
volume = {16},
number = {7},
pages = {33--43},
doi = {10.22270/jddt.v16i7.7858}
}
EUVIMED